Financials AXA

Equities

CS

FR0000120628

Life & Health Insurance

Market Closed - Euronext Paris 11:35:14 2024-07-12 EDT 5-day change 1st Jan Change
32.25 EUR +0.56% Intraday chart for AXA +0.91% +9.36%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 60,384 46,637 62,576 62,187 64,437 70,988 - -
Enterprise Value (EV) 1 51,536 90,842 59,292 94,301 96,039 84,388 84,388 84,388
P/E ratio 16.6 x 15.6 x 8.82 x 9.21 x 9.42 x 9.29 x 8.5 x 7.93 x
Yield 5.69% 7.33% 5.88% 6.52% 6.71% 6.64% 7.18% 7.67%
Capitalization / Revenue 0.58 x 0.48 x 0.63 x 0.61 x 0.77 x 0.66 x 0.63 x 0.61 x
EV / Revenue 0.5 x 0.94 x 0.59 x 0.92 x 1.15 x 0.79 x 0.75 x 0.72 x
EV / EBITDA - - - - - - - -
EV / FCF 6.14 x 3.61 x 9.6 x 12.5 x 16 x 14 x 13.2 x 12.6 x
FCF Yield 16.3% 27.7% 10.4% 7.98% 6.26% 7.15% 7.55% 7.96%
Price to Book 0.86 x 0.65 x 0.96 x 1.49 x 1.3 x 1.43 x 1.36 x 1.28 x
Nbr of stocks (in thousands) 2,404,779 2,390,174 2,389,774 2,386,757 2,185,051 2,201,172 - -
Reference price 2 25.11 19.51 26.18 26.06 29.49 32.25 32.25 32.25
Announcement Date 2/20/20 2/25/21 2/24/22 2/23/23 2/22/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 103,532 96,723 99,931 102,345 83,627 107,214 112,082 116,418
EBITDA - - - - - - - -
EBIT 1 5,841 4,264 9,514 9,329 9,218 9,467 10,200 11,218
Operating Margin 5.64% 4.41% 9.52% 9.12% 11.02% 8.83% 9.1% 9.64%
Earnings before Tax (EBT) 1 5,014 4,872 9,196 8,710 8,886 8,934 9,396 10,005
Net income 1 3,860 3,164 7,294 6,675 7,189 7,780 8,338 8,724
Net margin 3.73% 3.27% 7.3% 6.52% 8.6% 7.26% 7.44% 7.49%
EPS 2 1.510 1.250 2.970 2.830 3.130 3.470 3.794 4.066
Free Cash Flow 1 8,399 25,145 6,176 7,528 6,010 6,037 6,375 6,714
FCF margin 8.11% 26% 6.18% 7.36% 7.19% 5.63% 5.69% 5.77%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) 217.59% 794.72% 84.67% 112.78% 83.6% 77.6% 76.46% 76.96%
Dividend per Share 2 1.430 1.430 1.540 1.700 1.980 2.141 2.314 2.473
Announcement Date 2/20/20 2/25/21 2/24/22 2/23/23 2/22/24 - - -
1EUR in Million2EUR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S2 2020 S1 2020 S2 2021 S1 2021 S2 2022 Q1 2022 S1 2022 S2 2023 S1 2024 Q1 2024 S1
Net sales 1 - 52,391 - 53,865 46,066 23,294 55,141 47,204 40,715 34,345 -
EBITDA - - - - - - - - - - -
EBIT - 1,885 2,379 - - - - - - - -
Operating Margin - 3.6% - - - - - - - - -
Earnings before Tax (EBT) - - 2,552 - - - - - - - -
Net income - 1,429 - 3,996 - - 4,108 2,567 3,833 - 3,828
Net margin - 2.73% - 7.42% - - 7.45% 5.44% 9.41% - -
EPS 0.5900 0.5600 - 1.630 1.340 - 1.730 1.100 - - -
Dividend per Share - - - - - - - - - - -
Announcement Date 2/20/20 8/6/20 2/25/21 8/2/21 2/24/22 5/3/22 8/3/22 2/23/23 8/3/23 - -
1EUR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - 44,205 - 32,114 31,602 13,400 13,400 13,400
Net Cash position 1 8,848 - 3,284 - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 8,399 25,145 6,176 7,528 6,010 6,037 6,375 6,714
ROE (net income / shareholders' equity) 5.83% 4.47% 14.7% 12.8% 14.1% 15.6% 16% 16.2%
ROA (Net income/ Total Assets) 0.45% 0.58% 0.86% 0.99% 1.12% 1.18% 1.22% 1.29%
Assets 1 855,686 545,029 852,202 676,408 641,417 659,573 681,456 674,186
Book Value Per Share 2 29.30 30.00 27.40 17.50 22.70 22.60 23.80 25.20
Cash Flow per Share - 10.70 - - - - - -
Capex 1 - - - - - - - -
Capex / Sales - - - - - - - -
Announcement Date 2/20/20 2/25/21 2/24/22 2/23/23 2/22/24 - - -
1EUR in Million2EUR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
32.25 EUR
Average target price
38.46 EUR
Spread / Average Target
+19.24%
Consensus